House passes bill to reauthorize FDA user fee programs

Jun 09, 2022 - 02:53 PM
recissioin-legislation

The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding for the agency to review drugs, devices and biologics. Among other provisions, the bipartisan bill would include drugs on the FDA’s shortages list in a pilot program to designate advanced manufacturing technologies. The Senate Health, Education, Labor, and Pensions Committee will mark up their version of the bill Tuesday.

Related News Articles

Headline
Highest FDA recall issued for certain convenience kits
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
FDA announces highest recall for certain ventilators, introducer kits
The Food and Drug Administration has identified Class I recalls of two products: certain Astral ventilators by Resmed due to a supercapacitor that may leak…
Headline
Baxter recalls certain IV bags due to possible particulate matter 
Baxter is voluntarily recalling a specific lot of intravenous solution due to a report of particulate matter in the solution identified as cardboard, according…
Headline
FDA issues alert for certain Medline convenience kits 
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
FDA recalls certain first aid kits with TRUE METRIX blood glucose devices 
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Highest FDA recall issued for certain catheters, heart pump controllers
The Food and Drug Administration has identified a Class I recall of reprocessed electrophysiology and ultrasound catheters by Medline Industries due…